Neuphoria Therapeutics Announces Annual Meeting Voting Results; Elects Two Class I Directors

Neuphoria Therapeutics Inc.

Shareholders elected Peter Miles Davies (759,850 votes for) and David Wilson (758,571) as Class I directors.
Ratification of Wolf & Company P.C. as auditor passed with 807,022 votes in favor.
Non-binding advisory vote on executive compensation approved with 726,184 votes for.
On frequency of advisory votes, three years received the most votes (585,857), though non-binding.
Approximately 39.76% of outstanding shares (937,447) were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.